B-CELL LYMPHOMA RECURRENT
Clinical trials for B-CELL LYMPHOMA RECURRENT explained in plain language.
Never miss a new study
Get alerted when new B-CELL LYMPHOMA RECURRENT trials appear
Sign up with your email to follow new studies for B-CELL LYMPHOMA RECURRENT, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for lymphoma patients who Can't have stem cell transplants
Disease control OngoingThis study tests a treatment called axi-cel (a CAR T-cell therapy) for people with aggressive B-cell lymphoma that has come back or not responded to treatment. Participants are those who cannot have a standard stem cell transplant. The goal is to see if this therapy can shrink or…
Matched conditions: B-CELL LYMPHOMA RECURRENT
Phase: PHASE2 • Sponsor: The Lymphoma Academic Research Organisation • Aim: Disease control
Last updated Jun 15, 2026 19:04 UTC
-
Engineered immune cells take on tough blood cancers in early trial
Disease control OngoingThis early-stage trial tests a new treatment called MB-CART19.1 for people whose B-cell blood cancers (like leukemia or lymphoma) have returned or stopped responding to standard therapy. The treatment uses a patient's own immune cells, which are modified in a lab to better recogn…
Matched conditions: B-CELL LYMPHOMA RECURRENT
Phase: PHASE1 • Sponsor: Miltenyi Biomedicine GmbH • Aim: Disease control
Last updated Jun 12, 2026 12:08 UTC